相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multiple myeloma in the marrow: pathogenesis and treatments
Heather Fairfield et al.
MARROW (2016)
Advances in the pathogenesis and diagnosis of multiple myeloma
M. Chesi et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2015)
Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma
Enrica Borsi et al.
TRANSLATIONAL RESEARCH (2015)
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells
Rikio Suzuki et al.
PLOS ONE (2015)
Targeting Transcription Factors in Cancer
Anand S. Bhagwat et al.
TRENDS IN CANCER (2015)
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance
Ze Tian et al.
BLOOD (2014)
Targeting Mcl-1 for multiple myeloma (MM) therapy: Drug-induced generation of Mcl-1 fragment Mcl-1128-350 triggers MM cell death via c-Jun upregulation
Fengjuan Fan et al.
CANCER LETTERS (2014)
HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
Roberto Ria et al.
CLINICAL CANCER RESEARCH (2014)
The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells
Bettina Groetsch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Small Molecule Inhibitors Targeting Activator Protein 1 (AP-1)
Na Ye et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Targeting transcription factors: promising new strategies for cancer therapy
Jennifer E. Yeh et al.
CURRENT OPINION IN ONCOLOGY (2013)
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
Cory M. Johannessen et al.
NATURE (2013)
The role of tumour-stromal interactions in modifying drug response: challenges and opportunities
Douglas W. McMillin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Lack of BRAF V600E mutation in human myeloma cell lines established from myeloma patients with extramedullary disease
L. Lode et al.
BLOOD CANCER JOURNAL (2013)
Ets-1 Activates Overexpression of JunB and CD30 in Hodgkin's Lymphoma and Anaplastic Large-Cell Lymphoma
Mariko Watanabe et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
Dharminder Chauhan et al.
CANCER CELL (2012)
The diverse roles of IRF4 in late germinal center B-cell differentiation
Nilushi S. De Silva et al.
IMMUNOLOGICAL REVIEWS (2012)
JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma
T. Kanno et al.
ONCOGENE (2012)
A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression
Christina M. Annunziata et al.
BLOOD (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Significant Biological Role of Sp1 Transactivation in Multiple Myeloma
Mariateresa Fulciniti et al.
CLINICAL CANCER RESEARCH (2011)
Novel functions for NFκB: inhibition of bone formation
Susan A. Krum et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
A SNP Microarray and FISH-Based Procedure to Detect Allelic Imbalances in Multiple Myeloma: An Integrated Genomics Approach Reveals a Wide Gene Dosage Effect
Luca Agnelli et al.
GENES CHROMOSOMES & CANCER (2009)
Bone marrow microenvironment and the identification of new targets for myeloma therapy
K. Podar et al.
LEUKEMIA (2009)
The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling
Philipp B. Staber et al.
BLOOD (2007)
JunB is a gatekeeper for B-lymphoid leukemia
R. G. Ott et al.
ONCOGENE (2007)
AP-1 a target for cancer prevention
Connie P. Matthews et al.
CURRENT CANCER DRUG TARGETS (2007)
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis
Fenghuang Zhan et al.
BLOOD (2007)
Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma
Klaus Podar et al.
CANCER RESEARCH (2007)
Multiple myeloma bone disease: pathophysiology of osteoblast inhibition
Nicola Giuliani et al.
BLOOD (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
JunB expression is a common feature of CD30+lymphomas and lymphomatoid papulosis
GZ Rassidakis et al.
MODERN PATHOLOGY (2005)
Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma
EM Hurt et al.
CANCER CELL (2004)
BCL2 and JUNB abnormalities in primary cutaneous lymphomas
X Mao et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation
K Brocke-Heidrich et al.
BLOOD (2004)
AP-1: A double-edged sword in tumorigenesis
R Eferl et al.
NATURE REVIEWS CANCER (2003)
Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance
D Chauhan et al.
BLOOD (2003)
Characterization of the MM.1 human multiple myeloma (MM) cell lines: A model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells
S Greenstein et al.
EXPERIMENTAL HEMATOLOGY (2003)
Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas
X Mao et al.
BLOOD (2003)
The farnesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cells
SCE Bolick et al.
LEUKEMIA (2003)
Repression of AP-1 function: A mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene
FH Vasanwala et al.
JOURNAL OF IMMUNOLOGY (2002)
Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-κB
S Mathas et al.
EMBO JOURNAL (2002)
AP-1 as a regulator of cell life and death
E Shaulian et al.
NATURE CELL BIOLOGY (2002)
Expression pattern of the AP-1 family in endometrial cancer:: correlations with cell cycle regulators
AM Bamberger et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2001)
Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity
Y Chinenov et al.
ONCOGENE (2001)
Partners in transcription:: NFAT and AP-1
F Macián et al.
ONCOGENE (2001)
Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis
H van Dam et al.
ONCOGENE (2001)
Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking JunB expression in the myeloid lineage
E Passegué et al.
CELL (2001)
Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression
L Bakiri et al.
EMBO JOURNAL (2000)
分享论文
